热点话题人物,欢迎提交收录!
最优雅的名人百科,欢迎向我们提交收录。
李金龙
2023-05-11 13:53
  • 李金龙
  • 李金龙 - 教授 博导-南方医科大学-检验与生物技术学院-个人资料

近期热点

资料介绍

个人简历


1993.9-1996.7 山东临沂医学专科学校,临床医学\r
2000.9-2003.7 郑州大学,病理学与病理生理学,硕士\r
2003.9-2006.7 中山大学,肿瘤学,博士

研究领域


"""""1. 肿瘤耐药\r
2. 肿瘤免疫"

近期论文


Zhang Y, Xu L, Wang P, Jian H, Shi X, Jia M, Mo L, Hu Z, Li H, Li J. Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis. Cell Cycle. 2019;18(16):1938-1947.\r
\r
Mo L, Zhang X, Shi X, Wei L, Zheng D, Li H, Gao J, Li J, Hu Z. Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells. Cancer Sci. 2018;109(7): 2109-2118.\r
\r
Zheng D, Ye S, Wang X, Zhang Y, Yan D, Cai X, Gao W, Shan H, Gao Y, Chen J, Hu Z, Li H, Li J. Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity. Sci Rep 2017;7(1):2854.\r
\r
Li J, Luo J, Gu D, Jie F, Pei N, Li A, Chen X, Zhang Y, Du H, Chen B, Gu W, Sumners C, Li H. Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In Vivo. J Cancer 2016;7(2):184-191.\r
\r
Chen S, Chen X, Xie G, He Y, Yan D, Zheng D, Li S, Fu X, Li Y, Pang X, Hu Z, Li H, Tan W, Li J. Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells. Oncotarget 2016;7(26):40362-40376

相关热点

扫码添加好友